A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...
"The start of 2026 for EyePoint was marked by a strong quarter of consistent execution as we approach a pivotal inflection point for our lead program, DURAVYU," said (President, CEO & Director Jay ...
DENVER -- A sustained-release VEGF inhibitor implant outperformed standard anti-VEGF therapy for maintaining visual acuity in neovascular, or wet, age-related macular degeneration (AMD), showed a ...
Early safety and efficacy signals support move into repeat‑dose phase 2a trial PulseSight Therapeutics has unveiled positive phase 1 results for PST‑611, its non‑viral gene therapy candidate for dry ...
A new study by University of Maryland chemical physicists demonstrates how to control the nuclear spin of molecular hydrogen (H 2) by simply freezing it in dry ice. This new technique, published in ...
Hosted on MSN
Kansas exits ‘Money Follows the Person’ program, leaving nursing home residents hung out to dry
TOPEKA (KSNT) — The Kansas Department for Aging and Disability Services (KDADS) is eliminating a Medicaid program that helps nursing home residents’ transition back into community living. Obama's ...
Aalto University scientists have created a laser-based treatment that uses gentle heat to stop the progression of dry macular degeneration. The approach stimulates the eye’s natural cleanup and repair ...
PARIS, May 11, 2026 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive non-viral vectorized gene therapies with minimally-invasive ...
SOL-X long-term extension trial in wet AMD enrolled the first subject in April 2026 who had successfully completed the two-year SOL-1 trial Subjects who have completed the two-year follow-up in either ...
For context, analysts' consensus estimates called for revenue of $9.91 billion and adjusted EPS of $1.29, so AMD cleared both hurdles with room to spare. The company's gross profit margin expanded by ...
CNBC's Jim Cramer said AMD still has significant upside, arguing AI-driven demand for CPUs will keep pushing the stock higher. Cramer was responding to HSBC's downgrade of AMD to hold from buy. CNBC's ...
On April 16, Taiwan Semiconductor Manufacturing (TSM +2.11%) reported fantastic quarterly results, driven by "extremely robust" demand for AI chips, CEO C.C. Wei said on the earnings call. Earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results